Contact this trialFirst, we need to learn more about you.
Cytokine Inhibitor
Anakinra for Meniere's Disease
Recruiting1 awardPhase 2
New Hyde Park, New York
This trialwill test a drug, anakinra, in people with Meniere's and autoimmune inner ear diseases who don't respond to steroids. Patients will receive the drug or placebo for 42 days, then a second 42-day placebo period before 264 days of observation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service